Virta Health, a company on a mission to reverse Type 2 diabetes, today announced that it has raised $93 million in Series C funding to combat the
With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from the University of British
Novo Nordisk launched a handful of new insulin affordability offerings for people living in the U.S. The new offerings include: My$99Insulin:
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s Fiasp® (insulin aspart injection) 100 u/mL for use as a new mealtime
DexCom, Inc. has partnered with Tandem Diabetes Care in the UK, Sweden, Italy, and Spain to distribute the Dexcom G6 CGM System integrated with
The American Diabetes Association (ADA) released a new set of clinical standards that for the first time include the use of autonomous artificial
Using lipidomics, a technique that measures the composition of blood lipids at a molecular level, and machine learning, researchers at Lund
For the first time, scientists have been able to observe people developing Type 2 diabetes – and confirmed that fat over-spills from the liver
Just days after U.S. senators, Elizabeth Warren and Richard Blumenthal blasted Eli Lilly’s authorized generic program for insulins, claiming
Averitas Pharma, Inc., announced its supplemental New Drug Application (sNDA) for a new drug to treat neuropathic pain has been accepted by the U.S.
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: